Stocks Comparison
Niagen Bioscience vs Usana Health Sciences: revenue, profit, margins and growth compared
Niagen Bioscience brought in $129.4M of revenue in fiscal 2025, Usana Health Sciences $925.3M in fiscal 2025. Revenue changed by +29.9% at Niagen Bioscience and +8.3% at Usana Health Sciences on the year before, so Niagen Bioscience grew faster. Niagen Bioscience kept 13.4% of its revenue as net profit, Usana Health Sciences 1.2%.
Side by side, latest fiscal year
| NAGE | USNA | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (January 3, 2026) |
| Revenue | $129.4M | $925.3M |
| Revenue growth | +29.9% | +8.3% |
| Net income | $17.4M | $10.8M |
| Net margin | 13.4% | 1.2% |
| Free cash flow | n/a | $8.5M |
| Free cash flow margin | n/a | 0.9% |
| Earnings per share (diluted) | $0.20 | $0.58 |
| Cash | $64.8M | $158.4M |
| Debt | n/a | n/a |
| Price to earnings | 15.3 | 25.0 |
| Market value | $241.3M | $267.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #282 of 523 · Health care | #150 of 523 · Health care |
Over the years
Questions about Niagen Bioscience and Usana Health Sciences
Which is bigger by revenue, Niagen Bioscience or Usana Health Sciences?
Usana Health Sciences is bigger by revenue: $925.3M in fiscal 2025, against $129.4M for Niagen Bioscience in fiscal 2025.
Which keeps more of its revenue as profit, Niagen Bioscience or Usana Health Sciences?
Niagen Bioscience had a net margin of 13.4% in fiscal 2025; Usana Health Sciences had 1.2% in fiscal 2025.
Which grew revenue faster, Niagen Bioscience or Usana Health Sciences?
In their latest fiscal years revenue changed by +29.9% at Niagen Bioscience and +8.3% at Usana Health Sciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.